Position in LQDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$49,649,146
+$26,059,835 QoQ
Shares Held
622,716
-0.4% QoQ
Ownership
0.696%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#21
of 334 holders
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Derivatives in LQDA
reported options exposure · as of Sep 30, 2025CallValue
$1,655,472
CallShares
72,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BOOTHBAY FUND MANAGEMENT, LLC holds $84,777,886 across 22 Drug Manufacturers - Specialty & Generic names. LQDA ranks #1 (58.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
This page
|
622,716 | $49,649,146 | |
| 2 | ANIK |
Anika Therapeutics, Inc.
|
529,640 | $7,748,633 | |
| 3 | ANIP |
Ani Pharmaceuticals Inc
|
74,368 | $6,156,183 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
90,928 | $3,080,640 | |
| 5 | VTRS |
Viatris Inc
|
188,731 | $2,997,048 | |
| 6 | ETON |
Eton Pharmaceuticals, Inc.
|
57,516 | $2,082,079 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
11,814 | $1,991,131 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
56,774 | $1,968,354 |
All Filings in LQDA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,649,146 | 622,716 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $23,589,311 | 625,048 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $21,161,270 | 613,548 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $15,831,451 | 696,194 | Shares | Other | 2025-11-14 | |
| 2025-09-30 | $1,655,472 | 72,800 | Call | Other | 2025-11-14 | |
| 2025-06-30 | $8,209,744 | 658,888 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $9,777,376 | 662,873 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $6,569,818 | 558,658 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $5,586,580 | 558,658 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $6,703,896 | 558,658 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $8,240,205 | 558,658 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $6,720,655 | 558,658 | Shares | Other | 2024-02-14 | |
| 2022-06-30 | $1,500,912 | 344,246 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $165,175 | 23,005 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $157,963 | 32,436 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $243,409 | 88,192 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $313,564 | 109,638 | Shares | Other | 2021-08-17 | |
| 2021-03-31 | $265,546 | 98,716 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $291,212 | 98,716 | Shares | Other | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||